Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)

NCT01872858 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT01872858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01872858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2010
Completion date
November 30, 2015
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment